PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 137 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,785,357 | -74.8% | 406,796 | -58.3% | 0.00% | -80.0% |
| Q2 2023 | $26,923,810 | -28.9% | 974,794 | -40.8% | 0.01% | -37.5% |
| Q1 2023 | $37,869,040 | +28.2% | 1,646,480 | -39.2% | 0.01% | +14.3% |
| Q4 2022 | $29,538,978 | +191.0% | 2,707,514 | +124.8% | 0.01% | +133.3% |
| Q3 2022 | $10,152,000 | +95.4% | 1,204,187 | +83.4% | 0.00% | +200.0% |
| Q2 2022 | $5,195,000 | -39.2% | 656,729 | +81.9% | 0.00% | -50.0% |
| Q1 2022 | $8,549,000 | +70.1% | 361,024 | +145.7% | 0.00% | – |
| Q4 2021 | $5,026,000 | -33.6% | 146,948 | -65.6% | 0.00% | -100.0% |
| Q3 2021 | $7,574,000 | -60.7% | 427,404 | -0.5% | 0.00% | -75.0% |
| Q2 2021 | $19,277,000 | +257.5% | 429,508 | +106.3% | 0.00% | +300.0% |
| Q1 2021 | $5,392,000 | -21.5% | 208,218 | -38.9% | 0.00% | -50.0% |
| Q4 2020 | $6,871,000 | +107.4% | 340,822 | -27.4% | 0.00% | +100.0% |
| Q1 2020 | $3,313,000 | +2.4% | 469,212 | +2.2% | 0.00% | 0.0% |
| Q4 2019 | $3,236,000 | -35.3% | 459,093 | +10.3% | 0.00% | -50.0% |
| Q3 2019 | $4,999,000 | +0.7% | 416,255 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $4,963,000 | +8.6% | 409,847 | +12.7% | 0.00% | 0.0% |
| Q1 2019 | $4,572,000 | +1853.8% | 363,727 | +946.3% | 0.00% | – |
| Q4 2018 | $234,000 | -36.4% | 34,762 | -2.8% | 0.00% | – |
| Q3 2018 | $368,000 | -58.3% | 35,757 | -72.8% | 0.00% | – |
| Q2 2018 | $883,000 | +108.7% | 131,401 | +167.1% | 0.00% | – |
| Q1 2018 | $423,000 | – | 49,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |